Nabriva therapeutics plc

Major-Pharmaceuticals

NBRV


25-28 North Wall Quay
Dublin , 1

Executive/
Director

Price

  • Last Close
  • $ 1.42
    $ +0.01 0.71 %
    Jul 31, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 717,233
  • Market Cap Full
  • $ 4.6M
  • Shares Outstanding
  • 3.2M
    Sep 11, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -6.9% 101.3% -15.9% 67.1% -5% -32% -29.9% -6% - -
Q2 -16.3% -12.7% -26.9% -11.1% 4% -18.7% -56.7% -13.3% - -
Q3 -6% -21.9% -21.7% -18.6% 8% -11.9% 1042.9% -5.3% - -
Q4 -15.5% -27.5% -46.9% -32.5% 357.8% -49.7% -11.5% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%-38%0%-76%-9%83%-75%207%-23%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022
Q1 0.64 0.56 -0.04 -0.03 -0.25 -0.05 -0.5
Q2 0.56 0.54 -0.04 -0.03 -0.14 -0.03 -0.45
Q3 0.66 0.66 -0.09 -0.02 -0.09 -0.02 -0.42
Q4 0.69 0.60 -0.06 -0.29 -0.07 -0.27 -
A 2.6 2.4 -0.2 -11.2 -135.2 -28.5 -21.3

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 69.7 94.6 25 60.5 3.2
Jun 40.3 72.6 100 35.4 63.2 3.2
Sep 66.5 73.4 143.8 49.7 66.5 3.2
Dec 67 78.4 150.8 54.3 3.1 -

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover 0.1 0.1 - - -
Fixed Asset Turnover 4.1 3.2 5.8 2.8 2.5
Total Asset Turnover 0.1 0.1 0.1 0.1 0.1
Leverage
Debt Ratio 0.1 0.4 0.2 - -
Debt – Equity Ratio 0.2 0.8 0.4 - -
Interest Coverage -19.7 -24.3 -282.4 -125.5 59.4
Equity multiplier - 0.1 - - -